Medial EarlySign

Kfar Saba, Israel
AI platform that enables personal and outcome-based interpretation of medical records

About Medial EarlySign

Medial EarlySign is a company based in Kfar Saba (Israel).. Medial EarlySign has raised $30 million across 1 funding round from investors including aMoon, Horizons Ventures and Nir Kalkstein. The company has 23 employees as of December 31, 2024. Medial EarlySign offers products and services including AlgoMarkers. Medial EarlySign operates in a competitive market with competitors including Digital Reasoning, Agamon, Pieces Tech, Mednition and MaxQ-AI, among others.

  • Headquarter Kfar Saba, Israel
  • Employees 23 as on 31 Dec, 2024
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $30 M (USD)

    in 1 rounds

  • Latest Funding Round
    $30 M (USD), Series B

    Mar 06, 2018

  • Investors
    aMoon

    & 2 more

  • Employee Count
    23

    as on Dec 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Medial EarlySign

Medial EarlySign offers a comprehensive portfolio of products and services, including AlgoMarkers. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

AI models for predicting disease risks from clinical data.

People of Medial EarlySign
Headcount 10-50
Employee Profiles 6
Employee Profiles
People
Itai Katzir
Coo, CFO , Chief Commercial Officer EU
People
Rinat Gutman
VP, Product
People
Eran Choman
Chief Clinical Research And Compliance Officer
People
Itzik Vilmovsky
Senior Information Technology Manager

Unlock access to complete

Funding Insights of Medial EarlySign

Medial EarlySign has successfully raised a total of $30M through 1 strategic funding round. The most recent funding activity was a Series B round of $30 million completed in March 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Series B — $30.0M
  • First Round

    (06 Mar 2018)

  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2018 Amount Series B - Medial EarlySign Valuation aMoon
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Medial EarlySign

Medial EarlySign has secured backing from 3 investors, including venture fund and angel investors. Prominent investors backing the company include aMoon, Horizons Ventures and Nir Kalkstein. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Angel
Investor Description Founded Year Domain Location
Venture capital investments in healthcare are focused on by aMoon.
Founded Year Domain Location
Horizons Ventures is focused on investing in deep science and technology.
Founded Year Domain Location

Nir Kalkstein

Co-founder of Final, angel investor in Indian startups, tech enthusiast
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Medial EarlySign

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Medial EarlySign

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Medial Earlysign Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Medial EarlySign

Medial EarlySign operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Digital Reasoning, Agamon, Pieces Tech, Mednition and MaxQ-AI, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
AI-based consumer behavior analysis is offered for financial institutions.
domain founded_year HQ Location
Clinical data analytics are delivered via an AI cloud platform.
domain founded_year HQ Location
Adverse events are identified and prevented by AI predictive analytics.
domain founded_year HQ Location
EHR data is transformed into real-time clinical decision support.
domain founded_year HQ Location
Offers AI-based decision support tools for healthcare professionals to improve outcomes.
domain founded_year HQ Location
AI-based software for COVID-19 diagnosis via blood tests is provided.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Medial Earlysign

Frequently Asked Questions about Medial EarlySign

Where is Medial EarlySign located?

Medial EarlySign is headquartered in Kfar Saba, Israel. It is registered at Kfar Saba, Central District, Israel.

Is Medial EarlySign a funded company?

Medial EarlySign is a funded company, having raised a total of $30M across 1 funding round to date. The company's 1st funding round was a Series B of $30M, raised on Mar 06, 2018.

How many employees does Medial EarlySign have?

As of Dec 31, 2024, the latest employee count at Medial EarlySign is 23.

What does Medial EarlySign do?

A machine learning decision support tool is developed by Medial EarlySign for analyzing medical data. Individualized predictions and treatment options are provided for patients, along with early detection of conditions such as colorectal cancer. Analysis is performed instantly using standard medical records, with automatic alerts for high-risk cases. The company operates in the health technology sector from Kfar Saba, Israel.

Who are the top competitors of Medial EarlySign?

Medial EarlySign's top competitors include Agamon, Pieces Tech and Digital Reasoning.

What products or services does Medial EarlySign offer?

Medial EarlySign offers AlgoMarkers.

Who are Medial EarlySign's investors?

Medial EarlySign has 3 investors. Key investors include aMoon, Horizons Ventures, and Nir Kalkstein.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available